Clinical Trial Update: Treatment of Macrophage Activation Syndrome (MAS) With Anakinra [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating anakinra for macrophage activation syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macrophage Activation Syndrome

Drugs mentioned

• Anakinra (anakinra)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Macrophage Activation Syndrome | Phase 1 | Status: TERMINATED